These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9144358)

  • 61. Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity.
    Kao KJ; Scornik JC; Small SJ
    Transplantation; 1993 Jan; 55(1):192-6. PubMed ID: 8420047
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera.
    Ravindranath MH; Kaneku H; El-Awar N; Morales-Buenrostro LE; Terasaki PI
    J Immunol; 2010 Aug; 185(3):1935-48. PubMed ID: 20610644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapid and sensitive detection of immunoglobulin M (IgM) and IgG antibodies against canine distemper virus by a new recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay.
    von Messling V; Harder TC; Moennig V; Rautenberg P; Nolte I; Haas L
    J Clin Microbiol; 1999 Apr; 37(4):1049-56. PubMed ID: 10074525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 67. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
    Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
    Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation.
    Smith JD; Hamour IM; Burke MM; Mahesh B; Stanford RE; Haj-Yahia S; Robinson DR; Kaul P; Yacoub MH; Banner NR; Rose ML
    Transplantation; 2009 Mar; 87(6):864-71. PubMed ID: 19300190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
    Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
    Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT).
    Mulder A; Kardol M; Regan J; Buelow R; Claas F
    Hum Immunol; 1997; 56(1-2):106-13. PubMed ID: 9455499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HLA-antibody testing: the immune phagocytosis inhibition test is superior to the PRA-STAT and NIH lymphocytotoxic test with respect to specificity.
    Flesch BK; Philipp M; Cassens U; Neppert J
    J Clin Lab Anal; 2001; 15(6):334-41. PubMed ID: 11793435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.
    Ravindranath MH; Filippone EJ; Mahowald G; Callender C; Babu A; Saidman S; Ferrone S
    Immunol Res; 2018 Oct; 66(5):584-604. PubMed ID: 30324227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The detection by enzyme-linked immunosorbent assays of non-complement-fixing HLA antibodies in transfusion medicine.
    Lubenko A; Rodi KM
    Transfusion; 1998 Jan; 38(1):41-4. PubMed ID: 9482392
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primed CTLs specific for HLA class I may still be present in sensitized patients when anti-HLA antibodies have disappeared: relevance for donor selection.
    van Kampen CA; Versteeg-van der Voort Maarschalk MF; Roelen DL; Claas FH
    Transplantation; 2002 Apr; 73(8):1286-90. PubMed ID: 11981423
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro.
    Wassmuth R; Hauser IA; Schuler K; Erxleben H; Arnold ML; Koelman CA; Claas FH; Kalden JR
    Transplantation; 2001 May; 71(10):1436-42. PubMed ID: 11391232
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.
    Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL
    Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment of three methods of evaluating soluble class I HLA molecules in cell culture supernatants and serum samples from the second international workshop on soluble human leukocyte antigens.
    Nehlsen-Cannarella SL; Buckert L; Fagoaga O; Folz J; Grinde S; Hisey C; Schmitt R; Zappia J
    Hum Immunol; 1994 Jul; 40(3):210-7. PubMed ID: 7960965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.